Sanofi on Twitter: "Jean-François Toussaint, Head of Vaccines R&D has joined us at the #SanofiVaccines Investor Event with exciting updates on our pipeline: “We're opening a new chapter by entering new disease
![Sanofi on Twitter: "Today we announced positive topline results from a phase 2/3 trial in respiratory syncytial virus, or #RSV. These results are a next step toward our goal of helping to Sanofi on Twitter: "Today we announced positive topline results from a phase 2/3 trial in respiratory syncytial virus, or #RSV. These results are a next step toward our goal of helping to](https://pbs.twimg.com/media/E487a3AX0AEpJHh.jpg:large)
Sanofi on Twitter: "Today we announced positive topline results from a phase 2/3 trial in respiratory syncytial virus, or #RSV. These results are a next step toward our goal of helping to
![Pharmaceutical French group Sanofi-Aventis Chairman Jean-Francois Dehecq gives a speach during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on Pharmaceutical French group Sanofi-Aventis Chairman Jean-Francois Dehecq gives a speach during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on](https://c8.alamy.com/comp/2E95XC5/pharmaceutical-french-group-sanofi-aventis-chairman-jean-francois-dehecq-gives-a-speach-during-a-press-conference-to-present-the-full-year-2005-results-sanofi-aventis-announced-a-serie-of-positive-drug-research-developments-in-paris-on-february-24-2006-photo-by-christophe-guibbaudabacapresscom-2E95XC5.jpg)
Pharmaceutical French group Sanofi-Aventis Chairman Jean-Francois Dehecq gives a speach during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on
![Dr. Jean-Christophe Rufin to succeed Xavier Darcos as President of Sanofi Espoir Corporate Foundation | EuropaWire.eu | The European Union's press release distribution & newswire service Dr. Jean-Christophe Rufin to succeed Xavier Darcos as President of Sanofi Espoir Corporate Foundation | EuropaWire.eu | The European Union's press release distribution & newswire service](https://news.europawire.eu/wp-content/uploads/2020/09/Sanofi-Dr-Rufin-1280x720.jpg)
Dr. Jean-Christophe Rufin to succeed Xavier Darcos as President of Sanofi Espoir Corporate Foundation | EuropaWire.eu | The European Union's press release distribution & newswire service
Dr. Jean-Luc Lowinski, Sanofi Asia Senior Vice President and China President, Honored with 2016 Shanghai Magnolia Silver Award - PR Newswire APAC
Sanofi - Employees from our China and Emerging Markets office in Dubai celebrate Rare Disease Day | Facebook
![Pharmaceutical French group Sanofi-Aventis Chairman Jean-Francois Dehecq (L) listens to Gerard Le Fur (R), Executive Vice President for Scientific and Medical Operations, during a press conference to present the full-year 2005 results. Pharmaceutical French group Sanofi-Aventis Chairman Jean-Francois Dehecq (L) listens to Gerard Le Fur (R), Executive Vice President for Scientific and Medical Operations, during a press conference to present the full-year 2005 results.](https://c8.alamy.com/comp/2E95WGA/pharmaceutical-french-group-sanofi-aventis-chairman-jean-francois-dehecq-l-listens-to-gerard-le-fur-r-executive-vice-president-for-scientific-and-medical-operations-during-a-press-conference-to-present-the-full-year-2005-results-sanofi-aventis-announced-a-series-of-positive-drug-research-developments-in-paris-on-february-24-2006-photo-by-christophe-guibbaudabacapresscom-2E95WGA.jpg)